Search for company

Alembic Pharmaceuticals Ltd. (India)

Quote Chart
Quote Summary
Last Price 682.25
Volume 20,183
Turnover 13,714,349
Market Bombay Stock Exchange
Ticker 533573
Market Cap Market Cap 125,890,927
52 Week High 774.85
52 Week Low 390.70
P/E 43.92
EPS 15.2
Dividend Yield 2.5 (March 31, 2013)
Enterprise Value 87,086,838
Quote updated on November 27, 2015
Note: data in INR Thousands.
Select Items to chart them. 2016 Q2
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets N/A
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: Dion Global Solutions Limited, EMIS Company Database.
Company Description

Alembic Pharmaceuticals Limited develops, manufactures and markets pharmaceutical products, pharmaceutical substances and Intermediates. The company is in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The company was established in 1907 and hast its office based in Vadodara.

Main Products

pharmaceutical products, pharmaceutical substances and Intermediates

Contact Information

Legal Address
Alembic Road, ,
Vadodara; Gujarat; Map
Postal Code: 390003
Tel: 2280550/ 2280880/
Fax: 2282506

Full name: Alembic Pharmaceuticals Ltd.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
IN-CIN: U24230GJ2010PLC061123
Incorporation Date: 1907

Basic Information
Outstanding Shares:
: ()
Registered Capital:
Financial Auditors:
2014: Imports INR 1,933,192.00 Thousands
Import connections ('000)
2014: Exports INR 7,501,748.00 Thousands
Export connections ('000)
Key Executives
Chairman & Managing Director
Ownership Details
Indian Promoters
Affiliates and related companies
Alembic Global Holding SA
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - India

Register Your Interest

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.